Respiratory Tract

Cytology: Diagnostic Principles and Clinical Correlates

Volumn , Issue , 2009, Pages 65-103

  French, Christopher A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 76549106684     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5329-3.00002-5     Document Type: Chapter

References (197)

1. Johnston WW, Frable WJ Diagnostic Respiratory Cytopathology 1979, Masson Publishing, New York.
2. Linder J Lung cancer cytology. Something old, something new. Am J Clin Pathol 2000, 114:169-171.
3. Dahlgren S, Nordenstrom B Transthoracic Needle Biopsy 1966, Year Book Medical Publishers, Chicago.
4. Johnston WW Ten years of respiratory cytopathology at Duke University Medical Center. III. The significance of inconclusive cytopathologic diagnoses during the years 1970 to 1974. Acta Cytol 1982, 26:759-766.
5. Wax TD, Coogan AC, Johnston WW Clinical significance of an inconclusive cytopathologic diagnosis: A five-year experience at Duke University Medical Center. II. Analysis and follow-up of specimens from the respiratory tract. Acta Cytol 1997, 41(4):1053-1057.
6. The Papanicolaou Society of Cytopathology Task Force on Standards of Practice. Mod Pathol 1999, 12(4):427-436. Guidelines of the Papanicolaou Society of Cytopathology for the examination of cytologic specimens obtained from the respiratory tract.
7. Khajotia RR, Mohn A, Pokieser L, et al. Induced sputum and cytological diagnosis of lung cancer. Lancet 1991, 338:976-977.
8. Saccomanno G, Saunders RP, Ellis H, et al. Concentration of carcinoma or atypical cells in sputum. Acta Cytol 1963, 7:305-310.
9. Tang CS, Tang CM, Lau YY, Kung IT Sensitivity of sputum cytology after homogenization with dithiothreitol in lung cancer detection. Two years of experience. Acta Cytol 1995, 39(6):1137-1140.
10. Böcking A, Biesterfeld S, Chatelain R, et al. Diagnosis of bronchial carcinoma on sections of paraffin-embedded sputum: Sensitivity and specificity of an alternative to routine cytology. Acta Cytol 1992, 36:37-47.
11. Erozan YS, Frost JK Cytopathologic diagnosis of cancer in pulmonary material: A critical histopathologic correlation. Acta Cytol 1970, 14:560-565.
12. Fraire AE, Underwood RD, McLarty JW, Greenberg SD Conventional respiratory cytology versus fine needle aspiration cytology in the diagnosis of lung cancer. Acta Cytol 1991, 35(4):385-388.
13. Cytopathology of Pulmonary Disease 1988, S. Karger, Basel. D.L. Rosenthal (Ed.).
14. Sing A, Freudenberg N, Kortsik C, et al. Comparison of the sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas. Acta Cytol 1997, 41(2):399-408.
15. Suprun H, Pedio G, Ruttner JR The diagnostic reliability of cytologic typing in primary lung cancer with a review of the literature. Acta Cytol 1980, 24:494-500.
16. Liang XM Accuracy of cytologic diagnosis and cytotyping of sputum in primary lung cancer: Analysis of 161 cases. J Surg Oncol 1989, 40:107-111.
17. Pue CA, Pacht ER Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995, 107:430-432.
18. Popp W, Rauscher H, Ritschka L, et al. Diagnostic sensitivity of different techniques in the diagnosis of lung tumors with the flexible fiberoptic bronchoscope: Comparison of brush biopsy, imprint cytology of forceps biopsy, and histology of forceps biopsy. Cancer 1991, 67:72-75.
19. Kawan E, Ulrich W, Redtenbacher S, et al. Kawan bronchial brush/cell block technique. Facilitation of the routine diagnosis of bronchial neoplasms. Acta Cytol 1998, 42:1409-1413.
20. Raab SS, Oweity T, Hughes JH, et al. Effect of clinical history on diagnostic accuracy in the cytologic interpretation of bronchial brush specimens. Am J Clin Pathol 2000, 114(1):78-83.
21. Johnston WW Ten years of respiratory cytopathology at Duke University Medical Center. 1: The cytopathologic diagnosis of lung cancer during the years 1970 to 1974, noting the significance of specimen number and type. Acta Cytol 1981, 25:103-107.
22. Mak VH, Johnston ID, Hetzel MR, Grubb C Value of washings and brushings at fiberoptic bronchoscopy in the diagnosis of lung cancer. Thorax 1990, 45:373-376.
23. Kahn FW, Jones JM Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987, 155(5):862-869.
24. Pisani RJ, Wright AJ Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc 1992, 67:221-227.
25. Broaddus C, Dake MD, Stulbarg MS, et al. Bronchoalveolar lavage and transbronchial biopsy for the diagnosis of pulmonary infections in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 102:747-752.
26. Baughman RP, Dohn MN, Frame PT The continuing utility of bronchoalveolar lavage to diagnose opportunistic infection in AIDS patients. Am J Med 1994, 97(6):515-522.
27. Atzori C, Angeli E, Mainini A, et al. In vitro activity of human immunodeficiency virus protease inhibitors against Pneumocystis carinii. J Infect Dis 2000, 181(5):1629-1634.
28. Piller CF, Clark DP Pathologic outcome in HIV-seropositive individuals with nonspecific bronchoalveolar lavage cytology. Acta Cytol 1998, 42:913-917.
29. Pirozynski M Bronchoalveolar lavage in the diagnosis of peripheral, primary lung cancer. Chest 1992, 102(2):372-374.
30. Rennard SI Bronchoalveolar lavage in the diagnosis of cancer. Lung 1990, 168(Suppl):1035-1040.
31. Semenzato G, Poletti V Bronchoalveolar lavage in lung cancer. Respiration 1992, 9(Suppl 1):44-46.
32. Stanley MW, Henry-Stanley MJ, Gajl-Peczalska KJ, Bitterman PB Hyperplasia of type II pneumocytes in acute lung injury: Cytologic findings of sequential bronchoalveolar lavage. Am J Clin Pathol 1992, 97:669-677.
33. Gulbahce HE, Baker KS, Kumar P, et al. Atypical cells in bronchoalveolar lavage specimens from bone marrow transplant recipients. A potential pitfall. Am J Clin Pathol 2003, 120(1):101-106.
34. Policarpio-Nicolas ML, Wick MR False-positive interpretations in respiratory cytopathology: Exemplary cases and literature review. Diagn Cytopathol 2008, 36(1):13-19.
35. Herth FJ, Becker HD, Ernst A Ultrasound-guided transbronchial needle aspiration: an experience in 242 patients. Chest 2003, 123(2):604-607.
36. Herth FJ, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006, 61(9):795-798.
37. Yasufuku K, Chiyo M, Koh E, et al. Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer. Lung Cancer 2005, 50(3):347-354.
38. Harrow EM, Oldenburg FA, Smith AM Transbronchial needle aspiration to clinical practice. Thorax 1985, 40:756-759.
39. Baker JJ, Solanki PH, Schenk DA, et al. Transbronchial fine needle aspiration of the mediastinum: Importance of lymphocytes as an indicator of specimen adequacy. Acta Cytol 1990, 3:517-523.
40. Rosenthal DL, Wallace JM Fine needle aspiration of pulmonary lesions via fiberoptic bronchoscopy. Acta Cytol 1984, 28:203-210.
41. Bhat N, Bhagat P, Pearlman ES, et al. Transbronchial needle aspiration biopsy in the diagnosis of pulmonary neoplasms. Diagn Cytopathol 1990, 6:14-17.
42. Zakowski MF, Gatscha RM, Zaman MB Negative predictive value of pulmonary fine needle aspiration cytology. Acta Cytol 1992, 6:283-286.
43. Wagner ED, Ramzy I, Greenberg SD, Gonzalez JM Transbronchial fine-needle aspiration: Reliability and limitations. Am J Clin Pathol 1989, 92:36-41.
44. Rintoul RC, Skwarski KM, Murchison JT, et al. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J 2005, 25(3):416-421.
45. Singh P, Camazine B, Jadhav Y, et al. Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: A prospective study. Am J Respir Crit Care Med 2007, 175(4):345-354.
46. Eloubeidi MA, Tamhane A, Chen VK, Cerfolio RJ Endoscopic ultrasound-guided fine-needle aspiration in patients with non-small cell lung cancer and prior negative mediastinoscopy. Ann Thorac Surg 2005, 80(4):1231-1239.
47. Herth F, Becker HD, Ernst A Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration: a randomized trial. Chest 2004, 125(1):322-325.
48. Emery SC, Savides TJ, Behling CA Utility of immediate evaluation of endoscopic ultrasound-guided transesophageal fine needle aspiration of mediastinal lymph nodes. Acta Cytol 2004, 48(5):630-634.
49. Fernandez-Esparrach G, Gines A, Belda J, et al. Transesophageal ultrasound-guided fine needle aspiration improves mediastinal staging in patients with non-small cell lung cancer and normal mediastinum on computed tomography. Lung Cancer 2006, 54(1):35-40.
50. Vilmann P, Krasnik M, Larsen SS, et al. Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: A combined approach in the evaluation of mediastinal lesions. Endoscopy 2005, 37(9):833-839.
51. Westcott JL, Rao N, Colley DP Transthoracic needle biopsy of small pulmonary nodules. Radiology 1997, 202:97-103.
52. Agarwal PK, Husain N, Singh BN Cytologic findings in aspirated hydatid fluid. Acta Cytol 1989, 33:652-654.
53. Austin JHM, Cohen MB Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of lung: Report of 55 cancer patients and metaanalysis of the literature. Am J Roent 1993, 160:175-177.
54. Sacchini V, Galimberti V, Marchini S, Luini A Percutaneous transthoracic needle aspiration biopsy: A case report of implantation metastasis. Eur J Surg Oncol 1989, 15:179-183.
55. Zarbo RJ, Fenoglio-Preiser CM Interinstitutional database for comparison of performance in lung fine-needle aspiration cytology: A College of American Pathologists Q-probe study of 5264 cases with histologic correlation. Arch Pathol Lab Med 1992, 116:463-470.
56. Yazdi HM, MacDonald LL, Hickey NM Thoracic fine needle aspiration biopsy versus fine needle cutting biopsy: A comparative study of 40 patients. Acta Cytol 1988, 32:635-640.
57. Arslan S, Yilmaz A, Bayramgurler B, et al. CT-guided transthoracic fine needle aspiration of pulmonary lesions: accuracy and complications in 294 patients. Med Sci Monit 2002, 8(7):CR493-497.
58. Di Donna A, Bazzocchi M, Dolcet F, Springolo E [CT-guided transthoracic needle aspiration of solitary lung lesions. Personal experience in 118 cases]. Radiol Med (Torino) 1995, 89(3):287-294.
59. Hayes MM, Zhang DY, Brown W Transthoracic fine-needle aspiration biopsy cytology of pulmonary neoplasms. Diagn Cytopathol 1994, 10(4):315-319.
60. Arakawa H, Nakajima Y, Kurihara Y, et al. CT-guided transthoracic needle biopsy: A comparison between automated biopsy gun and fine needle aspiration. Clin Radiol 1996, 51(7):503-506.
61. Diacon AH, Theron J, Schubert P, et al. Ultrasound-assisted transthoracic biopsy: Fine-needle aspiration or cutting-needle biopsy?. Eur Respir J 2007, 29(2):357-362.
62. Greif J, Marmur S, Schwarz Y, et al. Percutaneous core cutting needle biopsy compared with fine-needle aspiration in the diagnosis of peripheral lung malignant lesions: Results in 156 patients. Cancer 1998, 84(3):144-147.
63. Cristallini EG, Ascani S, Farabi R, et al. Fine needle aspiration biopsy in the diagnosis of intrathoracic masses. Acta Cytol 1992, 36:416-422.
64. Castella X, Valles J, Cabezuelo MA, et al. Fat embolism syndrome and pulmonary microvascular cytology. Chest 1992, 101:1710-1711.
65. Abati A, Landucci D, Danner RL, Solomon D Diagnosis of pulmonary microvascular metastases by cytologic evaluation of pulmonary artery catheter-derived blood specimens. Hum Pathol 1994, 25:257-262.
66. Masson RG, Ruggieri J Pulmonary microvascular cytology. A new diagnostic application of the pulmonary artery catheter. Chest 1985, 88:908-914.
67. Dhooge I, Joos G, Van Cauwenberge P Value of rigid bronchoscopy and cytodiagnosis of bronchial washings in detecting bronchial carcinoma in the presence of a carcinoma of the upper aerodigestive tract. J Otolaryngol 1996, 25:219-222.
68. Roggli VL, Piantadosi CA, Bell DY Asbestos bodies in bronchoalveolar lavage fluid: A study of 20 asbestos-exposed individuals and comparison to patients with other chronic interstitial lung diseases. Acta Cytol 1986, 30:470-476.
69. Strickler JG, Manivel JC, Copenhaver CM, Kubic VL Comparison of in situ hybridization and immunohistochemistry for detection of cytomegalovirus and herpes simplex virus. Hum Pathol 1990, 21(4):443-448.
70. Weiss RL, Snow GW, Schumann GB, Hammond ME Diagnosis of cytomegalovirus pneumonitis on bronchoalveolar lavage fluid: Comparison of cytology, immunofluorescence, and in situ hybridization with viral isolation. Diagn Cytopathol 1991, 7:243-247.
71. Weinberg A, Hodges TN, Li S, et al. Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation. J Clin Microbiol 2000, 38(2):768-772.
72. Harboldt SL, Dugan JM, Tronic BS Cytologic diagnosis of measles pneumonia in a bronchoalveolar lavage specimen. A case report. Acta Cytol 1994, 38:403-406.
73. Pierce CH, Knox AW Ciliocytophthoria in sputum from patients with adenovirus infections. Proc Soc Exp Biol Med 1960, 104:492-495.
74. Osumi M, Toyoda T, Kawashiro T, Aoyagi T [Evaluation of a new detection method of Mycobacterium tuberculosis in clinical specimens by amplification of ribosomal RNA and its clinical application]. Kekkaku 1996, 71(10):573-585.
75. Qadri SM, Ali MA Sensitivity of fine-needle aspiration biopsy in the detection of mycobacterial infections. Diagn Cytopathol 1991, 7:142-146.
76. Das DK, Bhambhani S, Pant JN, et al. Superficial and deep-seated tuberculosis lesions: Fine-needle aspiration cytology diagnosis of 547 cases. Diagn Cytopathol 1992, 8:211-215.
77. DiTomasso JP, Ampel NM, Sobonya RE, Bloom JW Bronchoscopic diagnosis of pulmonary coccidioidomycosis. Comparison of cytology, culture, and transbronchial biopsy. Diagn Microbiol Infect Dis 1994, 18:83-87.
78. Raab SS, Silverman JF, Zimmerman KG Fine-needle aspiration biopsy of pulmonary coccidioidomycosis: Spectrum of cytologic findings in 73 patients. Am J Clin Pathol 1993, 99:582-587.
79. Iwama de Mattos MC, de Oliveira ML Respiratory cytopathology: Paracoccidioidomycosis associated either with tuberculosis or bronchogenic carcinoma. Diagn Cytopathol 1992, 8:198-199.
80. Iwama de Mattos MC, de Oliveira ML Pseudoepitheliomatous proliferation, a pitfall in sputum cytology. Diagn Cytopathol 1991, 7:656-657.
81. Iwama de Mattos MC, Mendes RP, Marcondes-Machado J, et al. Sputum cytology in the diagnosis of pulmonary paracoccidioidomycosis. Mycopathologica 1991, 114:187-191.
82. Farley ML, Fagan MF, Mabry LC, Wallace RJ Presentation of Sporothrix schenkii in pulmonary cytology specimens. Acta Cytol 1991, 35:389-395.
83. Ness MJ, Rennard SI, Vaughn WP, et al. Detection of Candida antigen in bronchoalveolar lavage fluid. Acta Cytol 1988, 32:347-352.
84. Edman JC, Kovacs JA, Masur H, et al. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 1988, 334:519-522.
85. Ypma-Wong MF, Fonzi WA, Sypherd PS Fungus-specific translation elongation factor 3 gene present in Pneumocystis carinii. Infect Immun 1992, 60:4140-4145.
86. Hartmann B, Koss M, Hui A, et al. Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome (AIDS): Diagnosis with bronchial brushings, biopsy, and bronchoalveolar lavage. Chest 1985, 87:603-607.
87. Maiese SC, Naryshkin S Diagnosis of Pneumocystis carinii by cytologic examination of Papanicolaou-stained sputum specimens. Diagn Cytopathol 1991, 7:111-112.
88. Naryshkin S, Daniels J, Freno E, Cunningham L Cytology of treated and minimal Pneumocystis carinii pneumonia and a pitfall of the Grocott methenamine silver stain. Diagn Cytopathol 1991, 7:41-47.
89. Kovacs JA, Ng VL, Masur H, et al. Diagnosis of Pneumocystis carinii pneumonia: improved detection in sputum with use of monoclonal antibodies. N Engl J Med 1988, 318:589-593.
90. Midgley J, Parsons PA, Shanson DC, et al. Monoclonal immunofluorescence compared with silver stain for investigating Pneumocystis carinii pneumonia. J Clin Pathol 1991, 44:75-76.
91. Hawkins AG, Hsiu JG, Smith RM, et al. Pulmonary dirofilariasis diagnosed by fine needle aspiration biopsy: A case report. Acta Cytol 1985, 29:19-22.
92. Ingram EA, Helikson MA Echinococcosis (hydatid disease) in Missouri: Diagnosis by fine-needle aspiration of a lung cyst. Diagn Cytopathol 1991, 7:527-553.
93. Aisner SC, Gupta PK, Frost JK Sputum cytology in pulmonary sarcoidosis. Acta Cytol 1977, 21:394-398.
94. Travis WD, Colby TV, Koss MN, et al. Atlas of Nontumor Pathology: Non-neoplastic Disorders of the Lower Respiratory Tract 2002, American Registry of Pathology and the Armed Forces Institute of Pathology, Washington, DC.
95. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999, 190(6):875-880.
96. Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med 2007, 356(6):567-579.
97. Beskow CO, Drachenberg CB, Bourquin PM, et al. Diffuse alveolar damage. Morphologic features in bronchoalveolar lavage fluid. Acta Cytol 2000, 44:640-646.
98. Hyakudo T, Yoshii C, Nikaido Y, et al. A case of bronchiolitis obliterans organizing pneumonia: Diagnostic utility of bronchoalveolar lavage and CT scan. Nihon Kyobu Shikkan Gakkai Zasshi 1994, 32:768-773.
99. Majori M, Poletti V, Curti A, et al. Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast. J Allergy Clin Immunol 2000, 105:239-244.
100. Poletti V, Cazzato S, Minicuci N, et al. The diagnostic value of bronchoalveolar lavage and transbronchial lung biopsy in cryptogenic organizing pneumonia. Eur Respir J 1996, 9:2513-2516.
101. Tiroke AH, Bewig B, Haverich A Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant 1999, 13:131-157.
102. Walts AE, Marchevsky AM, Morgan M Pulmonary cytology in lung transplant recipients: Recent trends in laboratory utilization. Diagn Cytopathol 1991, 7:353-358.
103. Minoletti F, Sozzi G, Calderone C, et al. Variant translocation t (6;10)(p21;q22) in pulmonary chondroid hamartoma. Genes Chromosomes Cancer 1996, 15:246-248.
104. Xiao S, Lux ML, Reeves R, et al. HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma. Am J Pathol 1997, 150:901-910.
105. Dunbar F, Leiman G The aspiration cytology of pulmonary hamartomas. Diagn Cytopathol 1989, 5:174-180.
106. Hughes JH, Young NA, Wilbur DC, et al. Fine-needle aspiration of pulmonary hamartoma: A common source of false-positive diagnoses in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 2005, 129(1):19-22.
107. Meis-Kindblom JM, Kjellstrom C, Kindblom LG Inflammatory fibrosarcoma: Update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors. Semin Diagn Pathol 1998, 15:133-143.
108. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000, 157:377-384.
109. Bridge JA, Kanamori M, Ma Z, et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001, 159(2):411-415.
110. Debiec-Rychter M, Marynen P, Hagemeijer A, Pauwels P ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003, 38(2):187-190.
111. Usuda K, Saito Y, Imai T, et al. Inflammatory pseudotumor of the lung diagnosed as granulomatous lesion by preoperative brushing cytology: A case report. Acta Cytol 1990, 34:685-689.
112. Füzesi L, Höer PW, Schmidt W Exfoliative cytology of multiple endobronchial granular cell tumor. Acta Cytol 1989, 33:516-518.
113. Mermolja M, Rott T Cytology of endobronchial granular cell tumor. Diagn Cytopathol 1991, 7:524-526.
114. Coissard CJ, Besson G, Polette MC, et al. Prevalence of human papillomaviruses in lung carcinomas: a study of 218 cases. Mod Pathol 2005, 18(12):1606-1609.
115. Nadal A, Campo E, Pinto J, et al. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium. Absence of a correlation with prognostic factors. J Pathol 1995, 175:181-188.
116. Rusch V, Klimstra D, Linkov I, Dmitrovsky E Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development. Cancer Res 1995, 55:1365-1372.
117. Vine MF, Schoenbach VJ, Hulka BS, et al. Atypical metaplasia and incidence of bronchogenic carcinoma. Am J Epidemiol 1990, 131:781-793.
118. Onuki N, Wistuba WD, Travis, et al. Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer 1999, 85:600-607.
119. Lam S, Becker HD Future diagnostic procedures. Chest Surg Clin N Am 1996, 6:363-380.
120. Hammond WG, Teplitz RL, Benfield JR Variable regression of experimental bronchial preneoplasia during carcinogenesis. J Thorac Cardiovasc Surg 1991, 101:800-806.
121. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
122. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart 2004, IARC Press, Lyon. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, C.C. Harris (Eds.).
123. Ahrendt SA, Chow JT, Xu LH, et al. Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 1999, 91:332-339.
124. Somers VA, Pietersen AM, Theunissen PH, Thunnissen FB Detection of K-ras point mutations in sputum from patients with adenocarcinoma of the lung by point-EXACCT. J Clin Oncol 1998, 16:3061-3068.
125. Hussain SP, Harris CC p53 mutation spectrum and load: The generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer. Mutat Res 1999, 428:23-32.
126. Fontana RS, Sanderson DR, Woolner LB, et al. Lung cancer screening: The Mayo program. J Occup Med 1986, 28:746-750.
127. McGee JMC Screening for lung cancer. Semin Surg Oncol 1989, 5:179-185.
128. Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002, 165(4):508-513.
129. Diederich S, Thomas M, Semik M, et al. Screening for early lung cancer with low-dose spiral computed tomography: Results of annual follow-up examinations in asymptomatic smokers. Eur Radiol 2004, 14(4):691-702.
130. Patz EF, Swensen SJ, Herndon JE Estimate of lung cancer mortality from low-dose spiral computed tomography screening trials: implications for current mass screening recommendations. J Clin Oncol 2004, 22(11):2202-2206.
131. Sone S, Li F, Yang ZG, et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 2001, 84(1):25-32.
132. Sone S, Nakayama T, Honda T, et al. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 2007, 58(3):329-341.
133. Jett JR Limitations of screening for lung cancer with low-dose spiral computed tomography. Clin Cancer Res 2005, 11(13 Pt 2):4988s-4992s.
134. Manser R, Dalton A, Carter R, et al. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting. Lung Cancer 2005, 48(2):171-185.
135. Pastorino U Early detection of lung cancer. Respiration 2006, 73(1):5-13.
136. Li R, Todd NW, Qiu Q, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 2007, 13(2 Pt 1):482-487.
137. Kersting M, Friedl C, Kraus A, et al. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers. J Clin Oncol 2000, 18(18):3221-3229.
138. Proctor L, Folpe AL, Esper A, et al. Well-differentiated fetal adenocarcinoma of the lung: Cytomorphologic features on fine-needle aspiration with emphasis on use of beta-catenin as a useful diagnostic marker. Diagn Cytopathol 2007, 35(1):39-42.
139. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304(5676):1497-1500.
140. Marchetti A, Martella C, Felicioni L, et al. EGFR mutations in non-small-cell lung cancer: Analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005, 23(4):857-865.
141. Haneda H, Sasaki H, Lindeman N, et al. A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma. Jpn J Clin Oncol 2006, 36(2):69-75.
142. Chen YR, Fu YN, Lin CH, et al. Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 2006, 25(8):1205-1215.
143. Okabe T, Okamoto I, Tamura K, et al. Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification. Cancer Res 2007, 67(5):2046-2053.
144. Greulich H, Chen TH, Feng W, et al. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med 2005, 2(11):e313.
145. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350(21):2129-2139.
146. Inoue A, Suzuki T, Fukuhara T, et al. Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations. J Clin Oncol 2006, 24(21):3340-3346.
147. Jackman DM, Yeap BY, Lindeman NI, et al. Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer. J Clin Oncol 2007, 25(7):760-766.
148. Engelman JA, Zejnullahu K, Mitsudomi T, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007, 316(5827):1039-1043.
149. Riely GJ, Kris MG, Zhao B, et al. Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus. Clin Cancer Res 2007, 13(17):5150-5155.
150. Smouse J, Cibas E, Janne P, et al. Cytology specimens compare favorably with surgical specimens for EGFR mutation detection in patients with NSCLC. Mod Pathol 2007, 20(Suppl 2):85A.
151. Horiike A, Kimura H, Nishio K, et al. Detection of epidermal growth factor receptor mutation in transbronchial needle aspirates of non-small cell lung cancer. Chest 2007, 131(6):1628-1634.
152. Chen KT Psammoma bodies in fine-needle aspiration cytology of papillary adenocarcinoma of the lung. Diagn Cytopathol 1990, 6:271-274.
153. Silverman JF, Finley JL, Park HK, et al. Psammoma bodies and optically clear nuclei in bronchioloalveolar cell carcinoma: Diagnosis by fine needle aspiration biopsy with histologic and ultrastructural confirmation. Diagn Cytopathol 1985, 1:205-215.
154. Ohori NP, Santa Maria EL Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 World Health Organization definition?. Am J Clin Pathol 2004, 122(1):44-50.
155. Mhoyan A, Weidner N, Shabaik A Epithelioid hemangioendothelioma of the lung diagnosed by transesophageal endoscopic ultrasound-guided fine needle aspiration: A case report. Acta Cytol 2004, 48(4):555-559.
156. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991, 15:529-553.
157. Hammond ME, Sause WT Large cell neuroendocrine tumors of the lung: Clinical significance and histopathologic definition. Cancer 1985, 56:1624-1629.
158. Iwasaki Y Large cell carcinoma. Nippon Rinsho 2000, 58:1127-1131.
159. Koss MN, Hochholzer L, O'Leary T Pulmonary blastomas. Cancer 1991, 67:2368-2381.
160. Holst VA, Finkelstein S, Colby TV, et al. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: Implications for histogenesis. Am J Surg Pathol 1997, 21:801-811.
161. Cosgrove MM, Chandrasoma PT, Martin SE Diagnosis of pulmonary blastoma by fine-needle aspiration biopsy: cytologic and immunocytochemical findings. Diagn Cytopathol 1991, 7:83-87.
162. Warren WM, Faber LP, Gould VE Neuroendocrine neoplasms of the lung: a clinicopathologic update. J Thorac Cardiovasc Surg 1989, 98:321-332.
163. Fekete PS, Cohen C, DeRose PB Pulmonary spindle cell carcinoid: Needle aspiration biopsy, histologic and immunohistochemical findings. Acta Cytol 1990, 34:50-56.
164. Jordan AG, Predmore L, Sullivan MM, Memoli VA The cytodiagnosis of well-differentiated neuroendocrine carcinoma: A distinct clinicopathologic entity. Acta Cytol 1987, 31:464-470.
165. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998, 22(8):934-944.
166. Renshaw AA, Voytek TM, Haja J, Wilbur DC Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005, 129(5):619-623.
167. Kalhor N, Zander DS, Liu J TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material. Mod Pathol 2006, 19(8):1117-1123.
168. Wu M, Wang B, Gil J, et al. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003, 119(5):696-702.
169. Dalton ML, Gatling RR Peripheral adenoid cystic carcinoma of the lung. South Med J 1990, 83:577-579.
170. Tonon G, Modi S, Wu L, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003, 33(2):208-213.
171. Lantuejoul S, Isaac S, Pinel N, et al. Clear cell tumor of the lung: An immunohistochemical and ultrastructural study supporting a pericytic differentiation. Mod Pathol 1997, 10:1001-1008.
172. Policarpio-Nicolas ML, Covell J, Bregman S, Atkins K Fine needle aspiration cytology of clear cell "sugar" tumor (PEComa) of the lung: Report of a case. Diagn Cytopathol 2008, 36(2):89-93.
173. Husain M, Nguyen GK Cytopathology of granular-cell tumor of the lung. Diagn Cytopathol 2000, 23(4):294-295.
174. Gal AA, Koss MN, Hochholzer L, Chejfec G An immunohistochemical study of benign clear cell ("sugar") tumor of the lung. Arch Pathol Lab Med 1991, 115:1034-1038.
175. Fleming WH, Jove DF Primary leiomyosarcoma of the lung with positive sputum cytology. Acta Cytol 1975, 19:14-20.
176. Moran CA, Suster S Tumors of the lung and pleura. Diagnostic Histopathology of Tumors 2007, 181-214. Churchill Livingstone, New York. 3rd ed. C. Fletcher (Ed.).
177. Stanfield BL, Powers CN, Desch CE, et al. Fine-needle aspiration cytology of an unusual primary lung tumor, chondrosarcoma: Case report. Diagn Cytopathol 1991, 7:423-426.
178. Nguyen GK Exfoliative cytology of angiosarcoma of the pulmonary artery. Acta Cytol 1985, 29:624-627.
179. Crosby JH, Hoeg K, Hager B Transthoracic fine needle aspiration of primary and metastatic sarcomas. Diagn Cytopathol 1985, 1:221-227.
180. Kim K, Naylor B, Han IH Fine needle aspiration cytology of sarcomas metastatic to the lung. Acta Cytol 1986, 30(6):688-694.
181. Flieder DB, Yousem SA Pulmonary lymphomas and lymphoid hyperplasias. Neoplastic Hematopathology 2001, 1263-1301. Williams & Wilkins, Baltimore, Lippincott. D. Knowles (Ed.).
182. Habermann TM, Ryu JH, Inwards DJ, Kurtin PJ Primary pulmonary lymphoma. Semin Oncol 1999, 26:307-315.
183. Pisani RJ, DeRemee RA Clinical implications of the histopathologic diagnosis of pulmonary lymphomatoid granulomatosis. Mayo Clin Proc 1990, 65:151-163.
184. Myers JL, Kurtin PJ, Katzenstein AL, et al. Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection. Am J Surg Pathol 1995, 19:1300-1312.
185. Zaer FS, Braylan RC, Zander DS, et al. Multiparametric flow cytometry in the diagnosis and characterization of low-grade pulmonary mucosa associated lymphoid tissue lymphomas. Mod Pathol 1998, 11:525-532.
186. Sprague RI, deBlois GG Small lymphocytic pulmonary lymphoma: diagnosis by transthoracic fine needle aspiration. Chest 1989, 96:929-930.
187. Reale FR, Variakojis D, Compton J, Bibbo M Cytodiagnosis of Hodgkin's disease in sputum specimens. Acta Cytol 1983, 27:258-261.
188. Rossi GA, Balbi B, Risso M, et al. Acute myelomonocytic leukemia: Demonstration of pulmonary involvement by bronchoalveolar lavage. Chest 1985, 87:259-260.
189. Riazmontazer N, Bedayat G Cytology of plasma cell myeloma in bronchial washing. Acta Cytol 1989, 33:519-522.
190. Rosen SE, Vonderheid EC, Koprowska I Mycosis fungoides with pulmonary involvement: cytopathologic findings. Acta Cytol 1984, 28:51-57.
191. Rosenblatt MB, Lisa JR, Trinidad S Pitfalls in the clinical and histologic diagnosis of bronchogenic carcinoma. Dis Chest 1966, 49:396-404.
192. Kern WH, Schweizer CW Sputum cytology of metastatic carcinoma of the lung. Acta Cytol 1976, 20:514-520.
193. Johnston WW Cytologic correlations. Pulmonary Pathology 1987, 1058. Springer-Verlag, New York. K. Dail, S. Hammer (Eds.).
194. Johnston WW Percutaneous fine needle aspiration biopsy of the lung: a study of 1,015 patients. Acta Cytol 1984, 28:218-224.
195. Zaman MB, Hajdu SI, Melamed MR, Watson RC Transthoracic aspiration cytology of pulmonary lesions. Semin Diagn Pathol 1986, 3:176-187.
196. Holzinger A, Dingle S, Bejarano PA, et al. Monoclonal antibody to thyroid transcription factor-1: Production, characterization, and usefulness in tumor diagnosis. Hybridoma 1996, 15:49-53.
197. Weir BA, Woo MS, Getz G, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450(7171):893-898.